drugset / Trial / NCT00031785
Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer
Phase 3
Completed
25 enrolled
Wake Forest University Health Sciences
National Cancer Institute (NCI) · collab
Supportive care
Summary
RATIONALE: Megestrol helps improve appetite. It is not yet known if megestrol is effective in limiting weight loss in patients who are undergoing radiation therapy. PURPOSE: Randomized phase III trial to determine the effectiveness of megestrol in limiting weight loss in patients who are undergoing radiation therapy for lung cancer.
Timeline
- Start
- 2000-09-01
- Primary completion
- 2002-09-11
- Completion
- 2002-09-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Megestrol Acetate | Other / unclassified | — | Oral |